forfivo xl

Generic: bupropion hydrochloride

Labeler: upsher-smith laboratories, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name forfivo xl
Generic Name bupropion hydrochloride
Labeler upsher-smith laboratories, llc
Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 450 mg/1

Manufacturer
Upsher-Smith Laboratories, LLC

Identifiers & Regulatory

Product NDC 24979-247
Product ID 24979-247_96a5dcb3-5d09-4357-96e3-8005ef094b2c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA022497
Listing Expiration 2026-12-31
Marketing Start 2023-12-15

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 24979247
Hyphenated Format 24979-247

Supplemental Identifiers

RxCUI
1232585 1232591
UPC
0324979247069
UNII
ZG7E5POY8O

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name forfivo xl (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number NDA022497 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 450 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-247-06)
source: ndc

Packages (1)

24979-247-06 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-247-06)

Ingredients (1)

bupropion hydrochloride (450 mg/1)

Linked Drug Pages (1)

Forfivo XL ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "96a5dcb3-5d09-4357-96e3-8005ef094b2c", "openfda": {"upc": ["0324979247069"], "unii": ["ZG7E5POY8O"], "rxcui": ["1232585", "1232591"], "spl_set_id": ["80b01182-dc94-4990-8ebb-55c306d7e536"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-247-06)", "package_ndc": "24979-247-06", "marketing_start_date": "20231215"}], "brand_name": "Forfivo XL", "product_id": "24979-247_96a5dcb3-5d09-4357-96e3-8005ef094b2c", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "24979-247", "generic_name": "bupropion hydrochloride", "labeler_name": "Upsher-Smith Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Forfivo", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "450 mg/1"}], "application_number": "NDA022497", "marketing_category": "NDA", "marketing_start_date": "20231215", "listing_expiration_date": "20261231"}